MX381723B - Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa. - Google Patents
Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa.Info
- Publication number
- MX381723B MX381723B MX2017007503A MX2017007503A MX381723B MX 381723 B MX381723 B MX 381723B MX 2017007503 A MX2017007503 A MX 2017007503A MX 2017007503 A MX2017007503 A MX 2017007503A MX 381723 B MX381723 B MX 381723B
- Authority
- MX
- Mexico
- Prior art keywords
- seq
- sortase
- enzyme
- novel methods
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/2207—Sortase A (3.4.22.70)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
La presente invención se refiere a un método para producir un producto de conjugación enzimática de dos polipéptidos caracterizado porque comprende los siguientes pasos -incubar i) un primer polipéptido que comprende la secuencia de aminoácidos LPXTG de SEC ID NO: 20, en donde X puede ser cualquier residuo de aminoácido, ii) un segundo polipéptido que comprende i) un compuesto de alaninilo en su extremo N-terminal, o ii) una oligo-alanina Am con m = 2 de SEC ID NO: 26, o 3 de SEC ID NO: 27, o 4 de SEQ ID NO: 28, O 5 DE SEQ ID NO: 29, o iii) un residuo de aminoácido de cisteína seguido por uno o tres residuos de aminoácidos de alanina en su extremo N-terminal, iii) un tercer polipéptido con actividad sortasa que se deriva de sortasa A de Staphylococcus aureus, y recuperar el conjugado de la mezcla de reacción y de este modo producir el producto de conjugación enzimática de dos polipéptidos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14198532 | 2014-12-17 | ||
| PCT/EP2015/079617 WO2016096741A1 (en) | 2014-12-17 | 2015-12-14 | Novel methods for enzyme mediated polypeptide conjugation using sortase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017007503A MX2017007503A (es) | 2017-10-04 |
| MX381723B true MX381723B (es) | 2025-03-13 |
Family
ID=52338848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017007503A MX381723B (es) | 2014-12-17 | 2015-12-14 | Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10190182B2 (es) |
| EP (1) | EP3233905B1 (es) |
| JP (1) | JP6618539B2 (es) |
| KR (1) | KR20170094216A (es) |
| CN (1) | CN107001447B (es) |
| BR (1) | BR112017010775A2 (es) |
| CA (1) | CA2966287A1 (es) |
| MX (1) | MX381723B (es) |
| RU (1) | RU2714963C2 (es) |
| SG (1) | SG11201704625UA (es) |
| WO (1) | WO2016096741A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106191015B (zh) * | 2016-08-25 | 2019-09-13 | 北京大学 | 金黄色葡萄球菌分选酶a高效突变体 |
| WO2022166913A1 (en) * | 2021-02-04 | 2022-08-11 | Westlake Therapeutics (Hangzhou) Co. Limited | Modified red blood cells and uses thereof for treating hyperuricemia and gout |
| CN118786207A (zh) * | 2022-01-12 | 2024-10-15 | 西湖生物医药科技(上海)有限公司 | 经修饰的细胞及其用途 |
| CN114487409B (zh) * | 2022-04-14 | 2022-07-19 | 启德医药科技(苏州)有限公司 | 一种转肽酶活性的检测方法及检测试剂盒 |
| CN116949004B (zh) * | 2023-07-13 | 2024-04-09 | 苏州源启生物科技有限公司 | 一种转肽酶Sortase A及其制备方法和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4150149A (en) | 1976-11-29 | 1979-04-17 | Professional Staff Association Of The Los Angeles County Harbor General Hospital | Method and means for the early detection and diagnosis of certain types of cancers |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4318980A (en) | 1978-04-10 | 1982-03-09 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a cycling reactant as label |
| US4444744A (en) | 1980-03-03 | 1984-04-24 | Goldenberg Milton David | Tumor localization and therapy with labeled antibodies to cell surface antigens |
| US4361544A (en) | 1980-03-03 | 1982-11-30 | Goldenberg Milton David | Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers |
| US5342606A (en) | 1984-10-18 | 1994-08-30 | Board Of Regents, The University Of Texas System | Polyazamacrocyclic compounds for complexation of metal ions |
| US5316757A (en) | 1984-10-18 | 1994-05-31 | Board Of Regents, The University Of Texas System | Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| EP0604580A1 (en) | 1991-09-19 | 1994-07-06 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
| US5428139A (en) | 1991-12-10 | 1995-06-27 | The Dow Chemical Company | Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals |
| US5739294A (en) | 1991-12-10 | 1998-04-14 | The Dow Chemical Company | Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents |
| US5480990A (en) | 1991-12-10 | 1996-01-02 | The Dow Chemical Company | Bicyclopolyazamacrocyclocarboxylic acid complexes for use as contrast agents |
| ZA932522B (en) | 1992-04-10 | 1993-12-20 | Res Dev Foundation | Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens |
| ATE139900T1 (de) | 1992-11-13 | 1996-07-15 | Idec Pharma Corp | Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma |
| US5385893A (en) | 1993-05-06 | 1995-01-31 | The Dow Chemical Company | Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| US5462725A (en) | 1993-05-06 | 1995-10-31 | The Dow Chemical Company | 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5834456A (en) | 1996-02-23 | 1998-11-10 | The Dow Chemical Company | Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6528624B1 (en) | 1998-04-02 | 2003-03-04 | Genentech, Inc. | Polypeptide variants |
| KR100797667B1 (ko) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | 외래 유전자의 전사를 조절하는 방법 |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| CN101490087B (zh) * | 2006-05-30 | 2013-11-06 | 健泰科生物技术公司 | 抗体和免疫偶联物及其用途 |
| US8940501B2 (en) * | 2009-01-30 | 2015-01-27 | Whitehead Institute For Biomedical Research | Methods for ligation and uses thereof |
| EP2403530B1 (en) | 2009-02-27 | 2016-05-11 | Massachusetts Institute of Technology | Engineered proteins with high affinity for dota chelates |
| EP2726494B1 (en) | 2011-06-28 | 2017-01-04 | Whitehead Institute For Biomedical Research | Using sortases to install click chemistry handles for protein ligation |
| ES2597228T3 (es) * | 2012-06-27 | 2017-01-17 | F. Hoffmann-La Roche Ag | Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas |
-
2015
- 2015-12-14 MX MX2017007503A patent/MX381723B/es unknown
- 2015-12-14 CA CA2966287A patent/CA2966287A1/en active Pending
- 2015-12-14 BR BR112017010775A patent/BR112017010775A2/pt active Search and Examination
- 2015-12-14 EP EP15817140.5A patent/EP3233905B1/en active Active
- 2015-12-14 RU RU2017122029A patent/RU2714963C2/ru active
- 2015-12-14 WO PCT/EP2015/079617 patent/WO2016096741A1/en not_active Ceased
- 2015-12-14 CN CN201580068354.2A patent/CN107001447B/zh active Active
- 2015-12-14 SG SG11201704625UA patent/SG11201704625UA/en unknown
- 2015-12-14 JP JP2017531742A patent/JP6618539B2/ja active Active
- 2015-12-14 KR KR1020177016141A patent/KR20170094216A/ko not_active Ceased
-
2017
- 2017-06-16 US US15/625,975 patent/US10190182B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017122029A (ru) | 2019-01-17 |
| CA2966287A1 (en) | 2016-06-23 |
| US10190182B2 (en) | 2019-01-29 |
| SG11201704625UA (en) | 2017-07-28 |
| RU2017122029A3 (es) | 2019-07-17 |
| JP2018500901A (ja) | 2018-01-18 |
| US20170292166A1 (en) | 2017-10-12 |
| JP6618539B2 (ja) | 2019-12-11 |
| EP3233905A1 (en) | 2017-10-25 |
| MX2017007503A (es) | 2017-10-04 |
| KR20170094216A (ko) | 2017-08-17 |
| EP3233905B1 (en) | 2020-01-29 |
| WO2016096741A1 (en) | 2016-06-23 |
| CN107001447B (zh) | 2021-07-23 |
| RU2714963C2 (ru) | 2020-02-21 |
| BR112017010775A2 (pt) | 2018-02-27 |
| CN107001447A (zh) | 2017-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017500785A1 (en) | INTERFERON a2B VARIANTS | |
| EA201490447A1 (ru) | Эндогликозидаза из streptococcus pyogenes и способы с применением указанной эндогликозидазы | |
| MY176331A (en) | Carbohydrate degrading polypeptide and uses thereof | |
| WO2015027258A3 (de) | Polypeptid zur hydrolytischen spaltung von zearalenon und/oder zearalenon-derivaten, isoliertes polynukleotid davon sowie einen zusatzstoff enthaltendes polypeptid, verwendung desselben sowie verfahren | |
| MX2022005119A (es) | Metodos de reduccion de olor. | |
| MX382218B (es) | Variantes de lipasa y polinucleotidos que las codifican. | |
| AU2015212749A8 (en) | Protein | |
| WO2015181119A3 (en) | Lipase variants and polynucleotides encoding same | |
| MX2017005642A (es) | Anticuerpos anti-angiopoyetina 2 (ang2) y metodos de uso. | |
| EP4374913A3 (en) | Novel human serum albumin mutant | |
| WO2016035007A3 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
| EP2533792A4 (en) | CHEMICAL PREPARATION OF POLYUBIQUITINE CHAINS | |
| MX2015001542A (es) | Metodo. | |
| MY169049A (en) | Microorganisms for producing putrescine and process for producing putrescine using them | |
| AU2015344324A8 (en) | Endoxylanase mutant, enzyme composition for biomass decomposition, and method for producing sugar solution | |
| MX2017007503A (es) | Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa. | |
| SG195302A1 (en) | Shk-based pharmaceutical compositions and methods of manufacturing and using the same | |
| EP4043558A3 (en) | Kaurenoic acid hydroxylases | |
| MY187334A (en) | Xylanase | |
| MX376535B (es) | Reacción enzimática en un solo recipiente para conjugación de polipéptido doble en un solo paso usando sortasa. | |
| CA2909744C (en) | Protransduzin b, an enhancer of gene transfer | |
| MX395506B (es) | CICLASA DE TETRAPRENIL-ß-CURCUMENO MUTADA Y MÉTODO PARA PRODUCIR AMBREÍNA. | |
| WO2015127365A3 (en) | Calcium-independent sortase a mutants | |
| MX2017012733A (es) | Produccion de compuestos fragantes. | |
| WO2017174769A3 (en) | Detergent compositions and uses of the same |